CollPlant Biotechnologies Ltd (CLGN) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

High Risk

Significant dilution risk

Last updated: July 09, 2026

Risk Assessment Details

Potential Dilution: 67.71% of current shares

Recent Dilution: 144.52% (2 years)

Historical Dilution Factor: significant recent dilution

Outstanding Shares

31M

Potential Supply

21M

Additional shares possible

Splits

None

Past 2 years

Summary

CLGN currently has 31M outstanding shares. with significant dilution risk as 21M authorized shares could dilute existing holders by 67.7%. The company has significantly diluted shareholders by 144.52% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Jul 09, 2026	F-3 filing: This filing relates to the resale of up to 31,047,068 ordinary shares, including shares issued in a private placement and shares underlying various classes of warrants.	31M	21M
Mar 30, 2026	F-1 filing: This is an F-1 filing for an offering of ordinary shares issuable upon exercise of warrants by selling shareholders.	14M	11M
Mar 26, 2026	20-F filing \| 12.2M shares outstanding	12M	10M
Jun 17, 2025	F-1 filing: This F-1 filing describes an offering of ordinary shares issuable upon exercise of Investor Warrants and Placement Agent Warrants.	13M	9.5M
Mar 26, 2025	20-F filing \| 11.5M shares outstanding	11M	9.5M
Apr 04, 2024	20-F filing \| 11.4M shares outstanding	11M	9.5M
Mar 29, 2023	20-F filing \| 11.0M shares outstanding	11M	9.9M
Dec 30, 2022	F-3 filing: CollPlant Biotechnologies Ltd. may offer, issue and sell from time to time up to US $100,000,000 of our ordinary shares, including in the form of warrants to purchase ordinary shares, subscription rights, and a combination of such securities, separately or as units, in one or more offerings.	10M	11M
Mar 24, 2022	20-F filing \| 10.0M shares outstanding	10M	0
Mar 26, 2021	20-F filing \| 7.0M shares outstanding	7M	2M
May 27, 2020	F-3 filing: This F-3 filing relates to the resale of up to 3,271,786 ordinary shares represented by ADSs by selling shareholders.	5.7M	3.3M
Apr 01, 2020	20-F filing \| 5.7M shares outstanding	5.7M	0

Back to CLGN Details